Cargando…

Effect of TNF-α-Induced Sclerostin on Osteocytes during Orthodontic Tooth Movement

Osteocytes are abundant cells in bone, which contribute to bone maintenance. Osteocytes express receptor activator of nuclear factor kappa-B ligand (RANKL) and regulate osteoclast formation. Orthodontic tooth movement (OTM) occurs by osteoclast resorption of alveolar bone. Osteocyte-derived RANKL is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ohori, Fumitoshi, Kitaura, Hideki, Marahleh, Aseel, Kishikawa, Akiko, Ogawa, Saika, Qi, Jiawei, Shen, Wei-Ren, Noguchi, Takahiro, Nara, Yasuhiko, Mizoguchi, Itaru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612957/ https://www.ncbi.nlm.nih.gov/pubmed/31341915 http://dx.doi.org/10.1155/2019/9716758

Ejemplares similares

TNF-α Directly Enhances Osteocyte RANKL Expression and Promotes Osteoclast Formation
por: Marahleh, Aseel, et al.
Publicado: (2019)

TNF-α is responsible for the contribution of stromal cells to osteoclast and odontoclast formation during orthodontic tooth movement
por: Ogawa, Saika, et al.
Publicado: (2019)

Effect of TNF-α on osteocyte RANKL expression during orthodontic tooth movement
por: Marahleh, Aseel, et al.
Publicado: (2021)

Establishment of an orthodontic retention mouse model and the effect of anti-c-Fms antibody on orthodontic relapse
por: Qi, Jiawei, et al.
Publicado: (2019)

Docosahexaenoic acid inhibits TNF-α-induced osteoclast formation and orthodontic tooth movement through GPR120
por: Ma, Jinghan, et al.
Publicado: (2023)

Micro-Osteoperforations Induce TNF-α Expression and Accelerate Orthodontic Tooth Movement via TNF-α-Responsive Stromal Cells
por: Kinjo, Ria, et al.
Publicado: (2022)

Effect of a DPP-4 Inhibitor on Orthodontic Tooth Movement and Associated Root Resorption
por: Qi, Jiawei, et al.
Publicado: (2020)

The osteocyte and its osteoclastogenic potential
por: Marahleh, Aseel, et al.
Publicado: (2023)

Docosahexaenoic Acid Inhibits Inflammation-Induced Osteoclast Formation and Bone Resorption in vivo Through GPR120 by Inhibiting TNF-α Production in Macrophages and Directly Inhibiting Osteoclast Formation
por: Kishikawa, Akiko, et al.
Publicado: (2019)

IL-33 Inhibits TNF-α-Induced Osteoclastogenesis and Bone Resorption
por: Ohori, Fumitoshi, et al.
Publicado: (2020)

Enhancement of orthodontic tooth movement and root resorption in ovariectomized mice
por: Nara, Yasuhiko, et al.
Publicado: (2022)

Osteocyte-Related Cytokines Regulate Osteoclast Formation and Bone Resorption
por: Kitaura, Hideki, et al.
Publicado: (2020)

Tumor necrosis factor-α enhances the expression of vascular endothelial growth factor in a mouse orthodontic tooth movement model
por: Noguchi, Takahiro, et al.
Publicado: (2022)

Anti-c-fms Antibody Prevents Osteoclast Formation and Bone Resorption in Co-Culture of Osteoblasts and Osteoclast Precursors In Vitro and in Ovariectomized Mice
por: Nara, Yasuhiko, et al.
Publicado: (2020)

C-X-C receptor 7 agonist acts as a C-X-C motif chemokine ligand 12 inhibitor to ameliorate osteoclastogenesis and bone resorption
por: Nugraha, Alexander Patera, et al.
Publicado: (2022)

Effects of Incretin-Related Diabetes Drugs on Bone Formation and Bone Resorption
por: Kitaura, Hideki, et al.
Publicado: (2021)

Role of the Interaction of Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors 1 and 2 in Bone-Related Cells
por: Kitaura, Hideki, et al.
Publicado: (2022)

Salt-Sensitive Hypertension Induces Osteoclastogenesis and Bone Resorption via Upregulation of Angiotensin II Type 1 Receptor Expression in Osteoblasts
por: Pramusita, Adya, et al.
Publicado: (2022)

Azilsartan inhibits inflammation-triggered bone resorption and osteoclastogenesis in vivo via suppression of TNF-α expression in macrophages
por: Fan, Ziqiu, et al.
Publicado: (2023)

Fermented Rice Bran Supplementation Inhibits LPS-Induced Osteoclast Formation and Bone Resorption in Mice
por: Noguchi, Takahiro, et al.
Publicado: (2023)

The Glucagon-Like Peptide-1 Receptor Agonist Exendin-4 Inhibits Lipopolysaccharide-Induced Osteoclast Formation and Bone Resorption via Inhibition of TNF-α Expression in Macrophages
por: Shen, Wei-Ren, et al.
Publicado: (2018)

Osteocytic Sclerostin Expression as an Indicator of Altered Bone Turnover
por: Huybrechts, Yentl, et al.
Publicado: (2023)

Sclerostin, Osteocytes, and Wnt Signaling in Pediatric Renal Osteodystrophy
por: Laster, Marciana, et al.
Publicado: (2023)

Osteocyte regulation of orthodontic force-mediated tooth movement via RANKL expression
por: Shoji-Matsunaga, Ayumi, et al.
Publicado: (2017)

IL-1β contributes to the secretion of sclerostin by osteocytes and targeting sclerostin promotes spinal fusion at early stages
por: Jiang, Zengxin, et al.
Publicado: (2023)

Osteocyte TSC1 promotes sclerostin secretion to restrain osteogenesis in mice
por: Liu, Wen, et al.
Publicado: (2019)

Elevated glucose acts directly on osteocytes to increase sclerostin expression in diabetes
por: Pacicca, Donna M., et al.
Publicado: (2019)

Kindlin-2 mediates mechanotransduction in bone by regulating expression of Sclerostin in osteocytes
por: Qin, Lei, et al.
Publicado: (2021)

Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent Pathway
por: Wijenayaka, Asiri R., et al.
Publicado: (2011)

Osteocytic oxygen sensing controls bone mass through epigenetic regulation of sclerostin
por: Stegen, Steve, et al.
Publicado: (2018)

Role of Muramyl Dipeptide in Lipopolysaccharide-Mediated Biological Activity and Osteoclast Activity
por: Kitaura, Hideki, et al.
Publicado: (2018)

The role of inhibition of osteocyte apoptosis in mediating orthodontic tooth movement and periodontal remodeling: a pilot study
por: Kaplan, Michele, et al.
Publicado: (2021)

Sclerostin Is an Osteocyte-expressed Negative Regulator of Bone Formation, But Not a Classical BMP Antagonist
por: van Bezooijen, Rutger L., et al.
Publicado: (2004)

Role of Osteocytes in Myeloma Bone Disease: Anti-sclerostin Antibody as New Therapeutic Strategy
por: Toscani, Denise, et al.
Publicado: (2018)

The Bromodomain Inhibitor N-Methyl pyrrolidone Prevents Osteoporosis and BMP-Triggered Sclerostin Expression in Osteocytes
por: Siegenthaler, Barbara, et al.
Publicado: (2018)

Impact of FasL Stimulation on Sclerostin Expression and Osteogenic Profile in IDG-SW3 Osteocytes
por: Kratochvilova, Adela, et al.
Publicado: (2021)

Sclerostin Promotes Bone Remodeling in the Process of Tooth Movement
por: Shu, Rui, et al.
Publicado: (2017)

Connecting the Dots: Linking Osteocyte Activity and Therapeutic Modulation of Sclerostin by Extending a Multiscale Systems Model
por: Eudy, RJ, et al.
Publicado: (2015)

Lipid Nanoparticle Delivery of siRNA to Osteocytes Leads to Effective Silencing of SOST and Inhibition of Sclerostin In Vivo
por: Basha, Genc, et al.
Publicado: (2016)

Tumor necrosis factor-α antagonist diminishes osteocytic RANKL and sclerostin expression in diabetes rats with periodontitis
por: Kim, Ji-Hye, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_h7i5gu4a04skkfo3a44lg7i1hv